NCT00443885View on ClinicalTrials.gov

Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Gram Negative Organism
Trial Locations (2)

15213

University of Pittsburgh Medical Center, Pittsburgh

UPMC, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT00443885 - Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC | Biotech Hunter | Biotech Hunter